Screener
Bio-Rad Laboratories BIO EBITDA
EBITDA at other companies
Other financials
Where this comes from
Calculated from Bio-Rad Laboratories’s reported figures.
The source filing: Bio-Rad Laboratories’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:19 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000012208-26-000035
FAQ
- What is Bio-Rad Laboratories's EBITDA?
- Bio-Rad Laboratories (BIO) reported EBITDA of $80.9M in Q1 2026.
- How has Bio-Rad Laboratories's EBITDA changed year-over-year?
- Bio-Rad Laboratories's EBITDA increased by 21.1% year-over-year, from $66.8M to $80.9M.
- What does EBITDA mean?
- Earnings before interest, taxes, depreciation, and amortization — EBIT plus the D&A add-back from the cash-flow statement (EBITDA = EBIT + D&A). A proxy for cash earnings that strips out financing, tax, and non-cash charges.
Ask your AI about Bio-Rad Laboratories's ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude